- Report
- March 2025
- 189 Pages
Global
From €3181EUR$3,545USD£2,738GBP
€3534EUR$3,939USD£3,042GBP
- Report
- April 2025
- 50 Pages
Global
From €2378EUR$2,650USD£2,047GBP
- Book
- July 2023
- 1568 Pages
Danofloxacin is an antibiotic used in animal pharmaceuticals to treat a variety of bacterial infections. It is a fluoroquinolone, a type of synthetic antibiotic, and is used to treat infections in a variety of animals, including cattle, horses, pigs, and poultry. Danofloxacin is effective against a wide range of Gram-positive and Gram-negative bacteria, and is used to treat respiratory, urinary, and gastrointestinal infections. It is also used to treat skin and soft tissue infections. Danofloxacin is available in a variety of formulations, including tablets, injections, and topical solutions.
The market for danofloxacin is driven by the increasing demand for animal pharmaceuticals, as well as the growing prevalence of bacterial infections in animals. The availability of danofloxacin in a variety of formulations has also contributed to its popularity.
Some companies in the danofloxacin market include Bayer AG, Merck & Co., Inc., Zoetis, Inc., Elanco Animal Health, Inc., and Virbac SA. Show Less Read more